GlassScriptPhysician profile
Michael R Lobis
NPI 1275582934
$7,928.02
in general payments reported to CMS, 2019-2025
40 companies · $1,937 in 2025
The $1,937 reported for 2025 was more than what 79% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,200 · 2020: $367 · 2021: $686 · 2022: $618 · 2023: $1,031 · 2024: $2,089 · 2025: $1,937.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,498 · Travel and Lodging: $381 · Education: $178.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,498.37 |
| Travel and Lodging | $380.56 |
| Education | $177.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $1,375.49 | 2019-2020 | |
| Procept Biorobotics Corporation | $706.05 | 2024-2025 | Aquabeam System |
| Astellas Pharma US INC | $687.56 | 2020-2025 | Xtandi, Myrbetriq |
| Sumitomo Pharma America, INC. | $682.31 | 2023-2025 | Gemtesa, Orgovyx |
| Bayer Healthcare Pharmaceuticals INC. | $577.99 | 2021-2025 | |
| Teleflex LLC | $439.14 | 2021-2024 | Urolift |
| Janssen Biotech, INC. | $407.20 | 2023-2025 | Erleada, Akeega |
| Tolmar, INC. | $332.10 | 2023-2025 | Eligard, Jatenzo, Rubraca |
| Progenics Pharmaceuticals, INC. | $309.96 | 2022-2025 | Pylarify |
| Coloplast Corp | $246.42 | 2022-2025 | Titan |
| Urogen Pharma, INC. | $188.58 | 2020-2025 | Jelmyto |
| Novartis Pharmaceuticals Corporation | $187.55 | 2025 | |
| Dendreon Pharmaceuticals LLC | $177.28 | 2021-2025 | Provenge |
| Abbvie INC. | $175.58 | 2020-2023 | |
| Telix Pharmaceuticals | $174.61 | 2023-2025 | Illuccix |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Lobis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.